Investor Relations
Investor Relations Contact:
LHA
Anne Marie Fields
212-838-3777
afields@lhai.com
or
Bruce Voss
310-691-7100
bvoss@lhai.com

Media Contact
Rooney & Associates
Terry Rooney
212-223-0689
trooney@rooneyco.com
or
Marion Janic
212-223-4017
mjanic@rooneyco.com

OPKO Receives FDA Orphan Drug Status for its New Oligonucleotide to Treat Genetic Neurological Disorder more »

OPKO Health's GeneDx to have Significant Presence at ACMG 2017 more »

OPKO Health to Participate in the Barclays Global Healthcare Conference more »

OPKO Receives EU Orphan Drug Status for its New Oligonucleotide to Treat Genetic Neurological Disorder¬† more »

Email Alert Subscription

If you have already signed up for OPKO Health, Inc. Email Alerts, please enter your email address in the field below and submit. A confirmation email will be sent. Please click on the link provided in the confirmation email to view your alert subscription. * Required fields

Email *
 
This helps OPKO Health, Inc. prevent automated submissions.
 

Email  Sign up for email alerts